Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.
DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.
Explores the development and challenges of antibody-based therapeutics, including chimeric and humanized antibodies, alternative scaffolds, and in vitro selection.
Introduces the emerging field of immunoengineering, covering interactions between engineering and immunology, genetically engineered immune cells for cancer therapy, and key technologies in immunological analysis.
Covers the evasion of immune pressure by tumors, cancer immunotherapies, drug delivery strategies, and the impact of nanoparticle characteristics on tumor penetration.
